Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Prashantha Kumar

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|October 13, 2024
Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant ratsShriram D Ranade, Shankar G Alegaon, Nayeem A Khatib, et al.
Bioorganic Chemistry|November 23, 2024
Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar ratsShankar Gharge, Shankar G Alegaon, Shriram D Ranade, et al.
Bioorganic Chemistry|June 2, 2019
Structure-based design and synthesis of new 4-methylcoumarin-based lignans as pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) inhibitorsS Santhosh Kumar, Ahil Sajeli Begum, Kirti Hira, et al.
Bioorganic Chemistry|October 16, 2012
Discovery of novel glitazones incorporated with phenylalanine and tyrosine: synthesis, antidiabetic activity and structure-activity relationshipsB R Prashantha Kumar, Nasir R Baig, Sai Sudhir, et al.
RSC Advances|April 10, 2024
Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer <i>via</i> EGFR inhibition: molecular design, synthesis, analysis and screeningSyed Faizan, Sirajunisa Talath, Adil Farooq Wali, et al.
RSC Advances|October 22, 2024
Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis<i>, in silico</i> evaluation, PPAR-γ binding assay and transactivation and expression studiesPriya D, Umme Hani, Nazima Haider, et al.
Computational Biology and Chemistry|November 18, 2021
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assayYuvaraj Sivamani, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Journal of Biomolecular Structure & Dynamics|September 7, 2021
Evaluation of flavonoids from banana pseudostem and flower (quercetin and catechin) as potent inhibitors of α-glucosidase: An in silico perspectiveShashank M Patil, Reshma Mary Martiz, Ramith Ramu, et al.
Drug Design, Development and Therapy|February 19, 2026
Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery StrategiesAhmed Raza Hashmi, Mahendran Sekar, Ling Shing Wong, et al.
European Journal of Medicinal Chemistry|February 1, 2011
Synthesis, glucose uptake activity and structure-activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linkerB R Prashantha Kumar, Mukesh Soni, S Santhosh Kumar, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|October 13, 2024
Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant ratsShriram D Ranade, Shankar G Alegaon, Nayeem A Khatib, et al.
Bioorganic Chemistry|November 23, 2024
Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar ratsShankar Gharge, Shankar G Alegaon, Shriram D Ranade, et al.
Bioorganic Chemistry|June 2, 2019
Structure-based design and synthesis of new 4-methylcoumarin-based lignans as pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) inhibitorsS Santhosh Kumar, Ahil Sajeli Begum, Kirti Hira, et al.
Bioorganic Chemistry|October 16, 2012
Discovery of novel glitazones incorporated with phenylalanine and tyrosine: synthesis, antidiabetic activity and structure-activity relationshipsB R Prashantha Kumar, Nasir R Baig, Sai Sudhir, et al.
RSC Advances|April 10, 2024
Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer <i>via</i> EGFR inhibition: molecular design, synthesis, analysis and screeningSyed Faizan, Sirajunisa Talath, Adil Farooq Wali, et al.
RSC Advances|October 22, 2024
Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis<i>, in silico</i> evaluation, PPAR-γ binding assay and transactivation and expression studiesPriya D, Umme Hani, Nazima Haider, et al.
Computational Biology and Chemistry|November 18, 2021
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assayYuvaraj Sivamani, Dhivya Shanmugarajan, T Durai Ananda Kumar, et al.
Journal of Biomolecular Structure & Dynamics|September 7, 2021
Evaluation of flavonoids from banana pseudostem and flower (quercetin and catechin) as potent inhibitors of α-glucosidase: An in silico perspectiveShashank M Patil, Reshma Mary Martiz, Ramith Ramu, et al.
Drug Design, Development and Therapy|February 19, 2026
Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery StrategiesAhmed Raza Hashmi, Mahendran Sekar, Ling Shing Wong, et al.
European Journal of Medicinal Chemistry|February 1, 2011
Synthesis, glucose uptake activity and structure-activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linkerB R Prashantha Kumar, Mukesh Soni, S Santhosh Kumar, et al.
Pageof 5